This content is current only at the time of printing. This document was printed on 30 May 2017. A current copy is located at https://apvma.gov.au/node/4141
You are here
Chief Executive Officer
Ms Kareena Arthy was appointed for a five-year term as chief executive officer on 1 January 2013.
Ms Arthy was Managing Director, Biosecurity Queensland for five years after its inception in 2007. An economics graduate, her career began as an econometrician with the Australian Bureau of Statistics in Canberra before becoming a senior economic analyst with the Department of the Prime Minister and Cabinet. Ms Arthy spent 10 years in the vocational education and training sector in various leadership roles in economic analysis, strategic policy and planning, communications, stakeholder management and federal–state relations.
Ms Arthy has led the APVMA during a period of major change including the introduction of regulatory reform, reducing the regulatory burden for industry and moving the Agency into the digital world while continuing to deliver on APVMA’s core business. The following key initiatives are a direct result of Ms Arthy’s leadership and has contributed to the APVMA being increasingly recognised as a contemporary world class regulator.
2014 Legislative Reforms
During 2014-15 the APVMA implemented a major legislative reform, and began an ambitious program of organisational change and business systems improvement.
The APVMA worked closely with industry and stakeholders to ensure they were ready for the reforms – delivering training sessions to over 600 people.
Reducing the regulatory burden for industry
The APVMA worked with industry to look at ways to lower the regulatory burden for industry when making an application, as well as improving the overall experience of applicants interacting and transacting with the APVMA.
The APVMA built and delivered new online services and a new website. This means that applications for approval and registration of chemicals, and payments of fees and levies can now be done through an integrated and secure online system. This new case management system delivers more efficient management of both applications and enquiries.
Improving timeframe performance
By September 2016 the APVMA was showing real signs of progress with timeframe performance for pesticide and veterinary medicine products at over 80 per cent. Major initiatives, legislative reform and cultural change have led to a much more pragmatic approach to assessing risk and the government’s policy for increased use of international assessments has been fully implemented.
Focus on regulatory science
Our regulatory science was strengthened with the appointment of a Chief Scientist by Ms Arthy.
The APVMA complemented and built in-house expertise by tapping into academic and industry scientific excellence through the science fellows program and use of external scientific assessors.
APVMA reviewed and strengthened its strategic risk-based approach to compliance. Awareness raising campaigns focussed on assisting people to return to voluntary compliance through education while a number of significant breaches of legislation were successfully resolved.
International leader in regulatory reform
Ms Arthy contributed to global harmonisation and leadership in agriculture and veterinary (agvet) chemical regulation, including chairing the major OECD committee for pesticide regulators.
Commitment to face-to-face engagement
APVMA’s commitment to face-to-face engagement with industry was commended with the establishment of industry information and education sessions.
Relocation to Armidale
The main elements of the relocation of the APVMA to Armidale are in place: the interim office in Armidale is operational; the business model for how the APVMA will operate in Armidale is close to finalisation; the detailed business case for the digital strategy will be provided to government soon; and a process to secure long term accommodation in Armidale is underway.